AI assistant
VERACYTE, INC. — Director's Dealing 2018
Mar 6, 2018
31551_dirs_2018-03-05_b25db2f6-44f8-4b6f-b906-ac97d1d55d99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2018-03-02
Reporting Person: Kennedy Keith (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-02 | Common Stock | A | 10300 | — | Acquired | 28114 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-02 | Stock Option (right to buy) | $5.98 | A | 77250 | Acquired | 2028-03-02 | Common Stock (77250.0) | Direct |
Footnotes
F1: Restricted stock units (RSUs) awarded on March 2, 2018 vest 25% on March 2, 2019, and the remaining vest at a rate of 3/48 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2: Includes 2,209 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2018.
F3: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous employment thereafter.